Role of mean platelet volume in triagging acute coronary syndromes
- 20 August 2007
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 26 (1) , 49-54
Abstract
Background: Acute coronary syndromes, characterized by the rupture of unstable plaque and the subsequent thrombotic process involving platelets, have been increasing in relative frequency. The central role of platelet activation has long been noticed in this pathophysiology; hence, many therapies have been directed against it. In this study, we have aimed to search prospectively the value of mean platelet volume (MPV), which is a simple and accurate measure of the functional status of platelets, in patients hospitalized with diagnosis of acute coronary syndromes (ACS). Materials and methods: A total of 216 consecutive patients (156 male, 60 female) hospitalized with the diagnosis of non-ST segment elevation (NSTE) ACS within the first 24 h of their chest pain were enrolled. One hundred and twenty patients, matched according to sex and age, with stable coronary heart disease (CHD) (85 male, 35 female) were enrolled as a control group. Patients were classified into two group: those with unstable angina (USAP, n = 105) and those with non-ST segment elevation myocardial infarction (NSTEMI, n = 111). Results: MPVs were 10.4 ± 0.6 fL, 10 ± 0.7 fL, 8.9 ± 0.7 fL consecutively for NSTEMI, USAP and stable CHD with significant differences. Patients with ischemic attacks in the first day of hospitalization accompanied by >0.05 mV ST segment shift had significantly higher MPV compared to those without such attacks (P = 0.001). Multivariable logistic regression analysis yielded that MPV (P = 0.016), platelet count (P < 0.001), and the presence of >0.05 mV ST segment depression at admission (P = 0.002) were independent predictors of development of NSTEMI in patients presenting with NSTE ACS. Conclusion: In patients presenting with NSTE ACS, higher MPV, though there are overlaps among subgroups, indicates not only more risk of having NSTEMI but also ischemic complications.Keywords
This publication has 30 references indexed in Scilit:
- Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.The American Journal of Cardiology, 1999
- Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest painEuropean Heart Journal, 1998
- Platelet glycoprotein IIb‐IIIa and size are increased in acute myocardial infarctionEuropean Journal of Clinical Investigation, 1994
- Influence of platelet size on outcome after myocardial infarctionThe Lancet, 1991
- Evidence for abnormal platelet glycoprotein expression in diabetes mellitusEuropean Journal of Clinical Investigation, 1990
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Arachidonic acid metabolism by platelets of differing sizeBritish Journal of Haematology, 1983
- Heterogeneity of human plateletsJournal of Clinical Investigation, 1969